Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Immunoglobulin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global immunoglobulin market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Also known as antibodies, immunoglobulins refer to a class of glycoprotein molecules produced by plasma or white blood cells (WBCs). They are generally present in the serum and cells of the immune system and function as antibodies by explicitly recognizing and binding antigens, such as bacteria or viruses, and aiding in their destruction. Their tests help doctors diagnose immunodeficiencies, allergies, and autoimmune conditions like juvenile idiopathic arthritis, lupus, and celiac disease. At present, different classes of immunoglobulins are available around the world depending on biological features, structure, target specificity, and distribution. 

Immunoglobulin Market Trends:

Due to rapid urbanization and hectic schedules, there is a rise in the consumption of fast food among individuals. This, along with sedentary lifestyles and the increasing number of patients with medical conditions like multiple myeloma, Waldenstrom macroglobulinemia, and autoimmune disorders, represents one of the primary factors impelling the growth of the market. Additionally, rising awareness about early diagnosis and the increasing preferences for personalized medicines are contributing to market growth. Moreover, immunoglobulins through a variety of routes of administration help the body fight various infectious diseases. As a result, with the rising number of hospitalized patients with coronavirus disease (COVID-19) and an urgent need for effective therapies to prevent the spread of the pandemic, hyperimmune globulin is utilized as an effective medicine in managing the infection. Apart from this, several pharmaceutical companies are introducing new and advanced immunoglobulins with improved efficiency for the treatment of neurological disorders. Other factors, such as increasing funding for research and development (R&D) projects and the improving healthcare infrastructure are anticipated to propel the market growth further in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global immunoglobulin market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, application and mode of delivery.

Breakup by Product:

  • IgG
  • IgA
  • IgM
  • IgE
  • IgD
     

Breakup by Application:

  • Hypogammaglobulinemia
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Immunodeficiency Disease
  • Myasthenia Gravis
  • Others
     

Breakup by Mode of Delivery:

  • Intravenous Mode of Delivery
  • Subcutaneous Mode of Delivery
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being ADMA Biologics Inc., Baxter international Inc., Biotest AG, CSL Limited, Grifols S.A, Kedrion S.p.A, LFB SA, Octapharma AG, Sanquin Plasma Products B.V. and Takeda Pharmaceutical Company Limited.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Product, Application, Mode of Delivery, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered ADMA Biologics Inc., Baxter international Inc., Biotest AG, CSL Limited, Grifols S.A, Kedrion S.p.A, LFB SA, Octapharma AG, Sanquin Plasma Products B.V. and Takeda Pharmaceutical Company Limited.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global immunoglobulin market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global immunoglobulin market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the mode of delivery?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global immunoglobulin market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Immunoglobulin Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product
    6.1    IgG
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    IgA
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    IgM
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    IgE
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    IgD
        6.5.1 Market Trends
        6.5.2 Market Forecast
7    Market Breakup by Application
    7.1    Hypogammaglobulinemia
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Immunodeficiency Disease
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Myasthenia Gravis
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8    Market Breakup by Mode of Delivery
    8.1    Intravenous Mode of Delivery
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Subcutaneous Mode of Delivery
        8.2.1 Market Trends
        8.2.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    ADMA Biologics Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
        14.3.2    Baxter international Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Biotest AG
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    CSL Limited
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Grifols S.A
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Kedrion S.p.A
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
        14.3.7    LFB SA
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Octapharma AG
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 SWOT Analysis
        14.3.9    Sanquin Plasma Products B.V.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
        14.3.10    Takeda Pharmaceutical Company Limited
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Immunoglobulin Market: Major Drivers and Challenges
Figure 2: Global: Immunoglobulin Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Immunoglobulin Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Immunoglobulin Market: Breakup by Product (in %), 2020
Figure 5: Global: Immunoglobulin Market: Breakup by Application (in %), 2020
Figure 6: Global: Immunoglobulin Market: Breakup by Mode of Delivery (in %), 2020
Figure 7: Global: Immunoglobulin Market: Breakup by Region (in %), 2020
Figure 8: Global: Immunoglobulin (IgG) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Immunoglobulin (IgG) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Immunoglobulin (IgA) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Immunoglobulin (IgA) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Immunoglobulin (IgM) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Immunoglobulin (IgM) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Immunoglobulin (IgE) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Immunoglobulin (IgE) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Immunoglobulin (IgD) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Immunoglobulin (IgD) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Immunoglobulin (Hypogammaglobulinemia) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Immunoglobulin (Hypogammaglobulinemia) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Immunoglobulin (Chronic Inflammatory Demyelinating Polyneuropathy-CIDP) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Immunoglobulin (Chronic Inflammatory Demyelinating Polyneuropathy-CIDP) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Immunoglobulin (Immunodeficiency Disease) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Immunoglobulin (Immunodeficiency Disease) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Immunoglobulin (Myasthenia Gravis) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Immunoglobulin (Myasthenia Gravis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Immunoglobulin (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Immunoglobulin (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Immunoglobulin (Intravenous Mode of Delivery) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Immunoglobulin (Intravenous Mode of Delivery) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: Immunoglobulin (Subcutaneous Mode of Delivery) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: Immunoglobulin (Subcutaneous Mode of Delivery) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: North America: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: North America: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: United States: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: United States: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Canada: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Canada: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Asia-Pacific: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Asia-Pacific: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: China: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: China: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Japan: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Japan: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: India: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: India: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: South Korea: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: South Korea: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Australia: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Australia: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Indonesia: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Indonesia: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Others: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Others: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Europe: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Europe: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Germany: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Germany: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: France: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: France: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: United Kingdom: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: United Kingdom: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Italy: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Italy: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Spain: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Spain: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Russia: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Russia: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Others: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Others: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Latin America: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Latin America: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Brazil: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Brazil: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Mexico: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Mexico: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Others: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Others: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 78: Middle East and Africa: Immunoglobulin Market: Sales Value (in Million US$), 2015 & 2020
Figure 79: Middle East and Africa: Immunoglobulin Market: Breakup by Country (in %), 2020
Figure 80: Middle East and Africa: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: Global: Immunoglobulin Industry: SWOT Analysis
Figure 82: Global: Immunoglobulin Industry: Value Chain Analysis
Figure 83: Global: Immunoglobulin Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Immunoglobulin Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Immunoglobulin Market Forecast: Breakup by Product (in Million US$), 2021-2026
Table 3: Global: Immunoglobulin Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 4: Global: Immunoglobulin Market Forecast: Breakup by Mode of Delivery (in Million US$), 2021-2026
Table 5: Global: Immunoglobulin Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Immunoglobulin Market: Competitive Structure
Table 7: Global: Immunoglobulin Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links